Total Valuation
GB Sciences has a market cap or net worth of $122.12K. The enterprise value is $1.87M.
Market Cap$122.12K
Enterprise Value$1.87M
Share Statistics
GB Sciences has 407,071,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding407,071,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
GB Sciences’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 39.97%.
Return on Equity (ROE)0.26
Return on Assets (ROA)-13.17
Return on Invested Capital (ROIC)39.97%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee0.00
Profits Per Employee-680.84K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GB Sciences is ―. GB Sciences’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio-0.49
Price to Fair Value-0.49
Price to FCF-2.64
Price to Operating Cash Flow-0.12
PEG Ratio0.03
Income Statement
In the last 12 months, GB Sciences had revenue of 0.00 and earned -1.36M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-624.00
Operating Income-1.42M
Pretax Income-1.36M
Net Income-1.36M
EBITDA-1.42M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -736.92K and capital expenditures 0.00, giving a free cash flow of -506.44K billion.
Operating Cash Flow-736.92K
Free Cash Flow-506.44K
Free Cash Flow per Share>-0.01
Dividends & Yields
GB Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-174.70
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
GB Sciences upcoming earnings date is Feb 15, 2018, Before Open (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateFeb 15, 2018
Ex-Dividend Date―
Financial Position
GB Sciences as a current ratio of 0.02, with Debt / Equity ratio of -33.11%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.68
Net Debt to EBITDA-1.23
Interest Coverage Ratio-6.49
Taxes
In the past 12 months, GB Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
GB Sciences EV to EBITDA ratio is -3.05, with an EV/FCF ratio of -4.43.
EV to Sales0.00
EV to EBITDA-3.05
EV to Free Cash Flow-4.43
EV to Operating Cash Flow-4.43
Balance Sheet
GB Sciences has $3.02K in cash and marketable securities with $1.99M in debt, giving a net cash position of -$1.99M billion.
Cash & Marketable Securities$3.02K
Total Debt$1.99M
Net Cash-$1.99M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for GB Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―